Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

179.33
Delayed Data
As of Sep 23
 -0.01 / -0.01%
Today’s Change
127.10
Today|||52-Week Range
196.47
-6.57%
Year-to-Date

Today’s Trading

Previous close179.34
Today’s open179.10
Day’s range177.81 - 181.20
Volume791,939
Average volume (3 months)1,071,105
Market cap$26.3B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+6.31%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+19.25%
P/E ratio61.4
Price/Sales12.89
Price/Book14.22

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.22-0.41%
TECHBio-Techne Corp-1.17-1.07%
XONIntrexon Corp-0.63-2.25%
JUNOJuno Therapeutics In...-0.51-1.67%
Data as of 4:01pm ET, 09/23/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Senior Vice President-Global Quality &
Operations
Robert P. Ragusa
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs